Skip to main content

Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial

Publication ,  Conference
Owens, E; Hotchkiss, KM; Norberg, P; Buckley, E; Ayasoufi, K; Threatt, S; Low, JT; Shoaf, ML; Goldston, M; Batich, K; Johnson, MO; Herndon, JE ...
Published in: Cancer Research
April 3, 2026

Duke Scholars

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

6477 / 6477

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Owens, E., Hotchkiss, K. M., Norberg, P., Buckley, E., Ayasoufi, K., Threatt, S., … Khasraw, M. (2026). Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. In Cancer Research (Vol. 86, pp. 6477–6477). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-6477
Owens, Elizabeth, Kelly M. Hotchkiss, Pamela Norberg, Evan Buckley, Katayoun Ayasoufi, Stevie Threatt, Justin T. Low, et al. “Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial.” In Cancer Research, 86:6477–6477. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-6477.
Owens E, Hotchkiss KM, Norberg P, Buckley E, Ayasoufi K, Threatt S, et al. Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6477–6477.
Owens, Elizabeth, et al. “Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 6477–6477. Crossref, doi:10.1158/1538-7445.am2026-6477.
Owens E, Hotchkiss KM, Norberg P, Buckley E, Ayasoufi K, Threatt S, Low JT, Shoaf ML, Goldston M, Batich K, Johnson MO, Herndon JE, Nair SK, Weinhold K, Friedman HS, Ashley DM, Desjardins A, Sampson JH, Khasraw M. Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6477–6477.

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

6477 / 6477

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology